Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q2 2023 Earnings Call Transcript August 8, 2023
Eagle Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.18, expectations were $1.05.
Operator: Good morning, everyone. My name is Shelby and I will be your conference operator. At this time, I’d like to welcome everyone to Eagle Pharmaceuticals’ Second Quarter 2023 Financial Results. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks,...
